Chroma Medicine Highlights Data Demonstrating Durable Multiplex Epigenetic Editing to Enhance Allogeneic CAR T at 65th ASH Annual Meeting

Multiplex allogeneic epigenetic edits demonstrate elimination of graft-versus-host disease and resistance of CD8+T, CD4+T, and NK cell responses, while preserving genomic integrity Chroma’s allogeneic approach has the potential to drive greater persistence of a CAR T relative to current…